Can a first disease-modifying osteoarthritis drug make it past the FDA?

Nature Reviews Drug Discovery 2026

View at publisher

Authors: Ken Garber

DOI: 10.1038/d41573-026-00047-z

Cited by: 1

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms Rheumatoid Arthritis Research and Therapies Bone Metabolism and Diseases